| Minireview: Addressing the retro-Michael instability of maleimide bioconjugates PA Szijj, C Bahou, V Chudasama Drug Discovery Today: Technologies 30, 27-34, 2018 | 141 | 2018 |
| A road map for prioritizing warheads for cysteine targeting covalent inhibitors P Abranyi-Balogh, L Petri, T Imre, P Szijj, A Scarpino, M Hrast, A Mitrović, ... European journal of medicinal chemistry 160, 94-107, 2018 | 129 | 2018 |
| Tyrosine bioconjugation–an emergent alternative PA Szijj, KA Kostadinova, RJ Spears, V Chudasama Organic & Biomolecular Chemistry 18 (44), 9018-9028, 2020 | 73 | 2020 |
| The renaissance of chemically generated bispecific antibodies P Szijj, V Chudasama Nature Reviews Chemistry 5 (2), 78-92, 2021 | 50 | 2021 |
| A Plug-and-Play Approach for the De Novo Generation of Dually Functionalized Bispecifics A Maruani, PA Szijj, C Bahou, JCF Nogueira, S Caddick, JR Baker, ... Bioconjugate Chemistry 31 (3), 520-529, 2020 | 49 | 2020 |
| Cysteine specific bioconjugation with benzyl isothiocyanates L Petri, PA Szijj, Á Kelemen, T Imre, Á Gömöry, MTW Lee, K Hegedűs, ... RSC advances 10 (25), 14928-14936, 2020 | 33 | 2020 |
| Modular chemical construction of IgG-like mono-and bispecific synthetic antibodies (SynAbs) F Thoreau, PA Szijj, MK Greene, LNC Rochet, IA Thanasi, JK Blayney, ... ACS Central Science 9 (3), 476-487, 2023 | 22 | 2023 |
| Chemical generation of checkpoint inhibitory T cell engagers for the treatment of cancer PA Szijj, MA Gray, MK Ribi, C Bahou, JCF Nogueira, CR Bertozzi, ... Nature chemistry 15 (11), 1636-1647, 2023 | 20 | 2023 |
| A Plug-and-Play Platform for the Formation of Trifunctional Cysteine Bioconjugates that also Offers Control over Thiol Cleavability C Bahou, PA Szijj, RJ Spears, A Wall, F Javaid, A Sattikar, EA Love, ... Bioconjugate Chemistry 32 (4), 672-679, 2021 | 20 | 2021 |
| Use of pyridazinediones as extracellular cleavable Linkers through Reversible Cysteine Conjugation C Bahou, RJ Spears, AE Aliev, A Maruani, M Fernandez, F Javaid, ... Chemical Communications 55 (98), 14829-14832, 2019 | 17 | 2019 |
| Employing defined bioconjugates to generate chemically functionalised gold nanoparticles for in vitro diagnostic applications DA Richards, MR Thomas, PA Szijj, J Foote, Y Chen, JCF Nogueira, ... Nanoscale 13 (27), 11921-11931, 2021 | 8 | 2021 |
| Site-directed conjugation of single-stranded DNA to affinity proteins: quantifying the importance of conjugation strategy AR Tapia, F Abgottspon, J Nilvebrant, PÅ Nygren, SD Ivetich, ... Chemical Science, 2024 | 1 | 2024 |
| Correction: Use of pyridazinediones as extracellular cleavable linkers through reversible cysteine conjugation C Bahou, RJ Spears, AE Aliev, A Maruani, M Fernandez, F Javaid, ... Chemical Communications 58 (91), 12740-12740, 2022 | 1 | 2022 |
| Formation of mono-and dual-labelled antibody fragment conjugates via reversible site-selective disulfide modification and proximity induced lysine reactivity I Thanasi, N Bouloc, C McMahon, N Wang, P Szijj, T Butcher, L Rochet, ... Chemical Science, 2025 | | 2025 |
| Site-Selective Antibody Conjugation with Dibromopyrazines D Szepesi Kovács, B Pásztor, P Ábrányi-Balogh, L Petri, T Imre, J Simon, ... Bioconjugate Chemistry 35 (9), 1373-1379, 2024 | | 2024 |
| Behind the paper: Chemical generation of checkpoint inhibitory T cell engagers for the treatment of cancer P Szijj, V Chudasama Chemistry, 2023 | | 2023 |
| Tyrosine bioconjugation-an emergent alternative (vol 18, pg 9018, 2020) PA Szijj, KA Kostadinova, RJ Spears, V Chudasama ORGANIC & BIOMOLECULAR CHEMISTRY, 2022 | | 2022 |
| Investigation of chemically constructed bispecific antibodies and their conjugates for the treatment of type 1 diabetes and cancer P Szijj University College London (UCL), 2022 | | 2022 |
| Correction: Tyrosine bioconjugation–an emergent alternative PA Szijj, KA Kostadinova, RJ Spears, V Chudasama Organic & Biomolecular Chemistry 20 (43), 8554-8555, 2022 | | 2022 |
| Chemically Generated Bispecific Antibodies–A New Dawn P Szijj, V Chudasama | | |
